Tufts Center for the Study of Drug Development

The Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation—now in its 52nd year—is a highly regarded, 4-day virtual program. It stands as the longest-running professional development course offering a comprehensive overview of the global drug development process and landscape. Top experts from industry, academia, and the FDA share their insights, creating an engaging and stimulating learning environment. Program dates: January 30, February 6, 13, 20; 11am-3pm EST. Visit https://lnkd.in/gEgrCeg for program details and to register. Group registration rates are available. To learn more, contact Sarah Wrobel, MHA at [email protected]

Tufts Center for the Study of Drug Development is thrilled to announce the launch of the PACT Consortium website. Discover our mission, goals, project updates, member organizations, and a downloadable summary report of year 1 initiatives—and much more. Visit https://lnkd.in/ehsWfC-h today! A special thank you to all member organizations who contributed to the success of the PACT Consortium’s first year. To learn more about the PACT Consortium or membership opportunities, please contact Joan Chambers at [email protected]. #clinicalresearch #DCT #datacollection #DCTSolutions

Mark your 2025 calendars! Advance your knowledge and understanding of the drug development and clinical research landscape with Tufts CSDD’s Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation. This 4-day virtual program is scheduled on the following Thursdays, from 11 AM to 3 PM EST: January 30, February 6, 13, and 20. Group registration rates are available. For more details and the program agenda, visit https://lnkd.in/gEgrCeg 

Connect with Tufts CSDD Director of Economic Analysis & Research Associate Professor Joseph DiMasi on November 13th at the 7th Annual Digital Implementation Summit in Cambridge for his presentation "Assessing the Net Financial Benefits of Employing Digital Endpoints in Clinical Trials". To browse other upcoming presentations from our team, visit https://lnkd.in/edbUE2nt

The sheer volume of data generated during clinical trials has increased exponentially over the past few years. In such circumstances how do you manage faster time to patient while managing costs and maintaining data integrity? Watch our on-demand session from the Life Sciences Summit by Egnyte and Google Cloud to learn more: https://bit.ly/3KDI4bl #LifeSciences Tufts Center for the Study of Drug Development #ClinicalTrials

DCT Solutions has the power to revolutionize clinical trials, optimize trial processes, improve patient outcomes, and enhance precision, and reliability in clinical research. The field of DCT is rapidly evolving and changing the drug development and clinical trials landscape. Be part of this initiative...Join the PACT Consortium Today. To learn more, contact Joan Chambers at [email protected] #PACTConsortium #DCTs #Collaboration

Explore the evolving global investigative site landscape with Tufts CSDD's new study, 'Mapping the New Global Investigative Site Landscape.' This research delves into emerging trends such as SMOs, Site Networks, clinical care-embedded staff, and innovative trial models like remote and mobile sites. Learn how these developments are transforming clinical trials and expanding access in local communities. For more information, contact Joan Chambers at [email protected]. #SiteLandscape #ClinicalTrials

🌟 Exciting insights from the 2024 DPHARM conference! Ken Getz of Tufts Center for the Study of Drug Development shared vital strategies for measuring ROI in decentralized clinical trials (DCTs). Key takeaways include: • Broad ROI Understanding: ROI transcends mere finance; it’s a language that drives innovation and investment. • ENPV Modeling: Essential for assessing drug development’s financial value, comparing commercial performance against investment costs. • PACT Consortium: Aiming for improved data collection to optimize DCT implementation. Explore more about how these insights can transform clinical research: Read the full article #ClinicalTrials #DecentralizedTrials #ROI #DCTs Allyson Adams Valerie Bowling

Now in its 52nd year, Tufts CSDD’s Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation equips drug developers, regulators, policymakers, clinical investigators, and researchers with the knowledge and skills for success in the life sciences sector. 🌟 What to Expect: ·         Insights from top speakers in industry, academia, and the FDA ·         A comprehensive overview of pharmaceutical development ·         A unique opportunity to network with thousands of alumni from around the globe 🎓 Whether you're new to the field or a seasoned professional, this course offers something for everyone. Plus, group rates are available for three or more colleagues. To learn more, email Sarah Wrobel, MHA at [email protected] 🔗 Learn more and register today: https://lnkd.in/gEgrCeg

Thank you to Pharma Focus Asia Magazine for highlighting this must-read article with Tufts CSDD Data Scientist Abigail Dirks, MS presenting a comprehensive assessment of risk-based quality management (RBQM) in clinical trials. Read the full article in Pharma Focus Asia, Magazine Issue 56: https://lnkd.in/gjymmJmM To explore more publications from CSDD, visit https://lnkd.in/evgdAAG9